SURMODICS INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021	FY2020 12 months to Sep 30, 2020
Revenue
Product Sales
Royalties and License Fees
Research, Development and Other
Total revenue
Operating costs and expenses:
Product costs
Research and development
Selling, general and administrative
Acquired intangible asset amortization
Restructuring expense
Contingent consideration (gain) expense
Acquisition transaction, integration and other costs
Total operating costs and expenses

Operating (loss) income
Other expense:
Interest expense, net
Foreign exchange (loss) gain
Investment income, net
Loss on strategic investments and other
Other expense, net

(Loss) income before income taxes
Income tax expense
Net loss
Basic net loss per share
Diluted net loss per share
Weighted average number of shares outstanding:
Basic
Diluted

Comments